Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.4%
    Check dated 2025-05-08T13:39:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-05-01T06:10:01.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding a phase I/II trial of pembrolizumab for CD19+ lymphomas, while adding a new study identifier and a revision number.
    Difference
    46%
    Check dated 2025-04-16T17:47:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.14.3 to v2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T11:47:54.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The term 'Lymphosarcoma' has been removed and replaced with 'B-cell Lymphoma'.
    Difference
    0.5%
    Check dated 2025-04-01T23:51:32.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T14:36:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.